Related Experiment Video
Updated: Aug 23, 2026

Murine Full-thickness Skin Transplantation
Published on: January 2, 2017
New concepts in organ transplantation
K Praditpornsilpa1, Y Avihingsanon
1Division of Nephrology, Department of Medicine, Chulalongkorn University Hospital, Bangkok, Thailand. Kearkiat@hotmail.com
Abstract:
Long-term graft survival is the desired outcome of organ transplantation. The surrogate metric elimination of acute rejection episodes is not only inadequate but also deceptive, since this freedom does not promise long-term graft survival. Current clinical immunosuppressive agents have reduced acute rejection, but not prolonged graft survival. New paradigms in organ transplantation focus on adhesion-migration events using a selectin antagonist, an antisense oligonucleotide, and FTY 720; on peptide or allochimeric antigens on cytokine disruption, and on inhibition of costimulatory signals. Due to the array of adverse reactions to the available immunosuppressive drugs, these new approaches aim not only to augment long-term graft survival, but also minimize the associated toxicities.
Insights
Organ transplant success requires long-term graft survival, not just preventing acute rejection. New strategies aim to improve survival and reduce drug toxicity for better transplant outcomes.
Area of Science:
- Immunology
- Transplantation Medicine
- Pharmacology
Background:
- Long-term graft survival is the primary goal in organ transplantation.
- Current immunosuppressive drugs reduce acute rejection but do not improve long-term graft survival.
- Acute rejection episodes are an inadequate surrogate for long-term graft success.
Purpose of the Study:
- To explore new therapeutic paradigms in organ transplantation.
- To identify strategies that improve long-term graft survival.
- To minimize toxicities associated with current immunosuppressive agents.
Main Methods:
- Investigating novel approaches targeting adhesion-migration pathways.
- Utilizing selectin antagonists, antisense oligonucleotides, and FTY 720.
- Exploring peptide/allochimeric antigens, cytokine disruption, and costimulatory signal inhibition.
Main Results:
- New approaches focus on mechanisms beyond acute rejection.
- Strategies aim to enhance graft survival and reduce drug side effects.
- The study highlights a shift towards more targeted immunosuppression.
Conclusions:
- Current immunosuppression is insufficient for long-term graft survival.
- Novel therapeutic strategies offer promise for improved transplant outcomes.
- Minimizing drug toxicity is a key objective in developing new treatments.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

